Blasingham M C, Nasjletti A
Am J Physiol. 1979 Sep;237(3):F182-7. doi: 10.1152/ajprenal.1979.237.3.F182.
To study the effects of stimulation of renal prostaglandin biosynthesis by bradykinin, we assessed the changes in renal functions induced by intrarenal infusion of bradykinin (10 ng . min-1 . kg-1) in the dog anesthetized with pentobarbital before and during inhibition of prostaglandin synthesis by sodium meclofenamate (5 mg/kg). Before meclofenamate administration, bradykinin augmented the urinary output of a "PGE"-like substance from 1.00 +/- 0.25 to 3.88 +/- 1.09 ng/min (P less than 0.05) and increased renal blood flow by 65 +/- 9 ml/min (P less than 0.001), urine flow by 0.55 +/- 0.23 ml/min (P less than 0.05), and sodium excretion by 64.8 +/- 18.0 mueq/min (P less than 0.01). Administration of meclofenamate did not affect the bradykinin-induced increase in renal blood flow and urine volume, but suppressed the evoked output of "PGE" and reduced the associated natriuresis, i.e., sodium excretion increased by only 11.1 +/- 4.8 mueq/min (P greater than 0.05). In contrast, meclofenamate did not affect the natriuresis effected by an equidilator dose of PGE2 (5 ng . min-1 . kg-1) infused intrarenally. These observations suggest that a product of prostaglandin synthetase produced by the kidney during intrarenal infusion of bradykinin contributes to the natriuretic action of the peptide.
为研究缓激肽刺激肾前列腺素生物合成的作用,我们评估了在戊巴比妥麻醉的犬体内,于用甲氯芬那酸钠(5mg/kg)抑制前列腺素合成之前及期间,肾内输注缓激肽(10ng·min⁻¹·kg⁻¹)所诱导的肾功能变化。在给予甲氯芬那酸钠之前,缓激肽使一种“PGE”样物质的尿排出量从1.00±0.25ng/min增加至3.88±1.09ng/min(P<0.05),肾血流量增加65±9ml/min(P<0.001),尿流量增加0.55±0.23ml/min(P<0.05),钠排泄增加64.8±18.0μeq/min(P<0.01)。给予甲氯芬那酸钠并不影响缓激肽诱导的肾血流量和尿量增加,但抑制了“PGE”的诱发排出量并减少了相关的利钠作用,即钠排泄仅增加11.1±4.8μeq/min(P>0.05)。相反,甲氯芬那酸钠并不影响肾内输注等剂量扩张血管的PGE2(5ng·min⁻¹·kg⁻¹)所产生的利钠作用。这些观察结果提示,肾内输注缓激肽期间肾脏产生的前列腺素合成酶产物有助于该肽的利钠作用。